Cargando…
618. Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection?
BACKGROUND: Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (rCDI). Few studies have evaluated clinical factors associated with microbial engraftment. We describe microbial changes post-FMT and clinical factors impacting engraftment. MET...
Autores principales: | Budree, Shrish, Osman, Majdi, Panchal, Pratik, Shu, Edina, Carrellas, Madeline, Kassam, Zain, Allegretti, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254229/ http://dx.doi.org/10.1093/ofid/ofy210.625 |
Ejemplares similares
-
533. Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis
por: Panchal, Pratik, et al.
Publicado: (2018) -
Framework for rational donor selection in fecal microbiota transplant clinical trials
por: Duvallet, Claire, et al.
Publicado: (2019) -
Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017) -
Pilot study of autologous fecal microbiota transplants in nursing home residents: Feasibility and safety()
por: Liu, Christine K., et al.
Publicado: (2022) -
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016)